Glaxosmithkline Pharmaceuticals per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹62.01₹54.52₹54.52₹34.83₹36.05
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹63.05₹54.76₹54.76₹34.83₹36.05
₹133.84₹133.84₹115.18₹104.93₹102.78
₹233.45₹225.59₹221.31₹203.87₹191.94
—₹53.32₹76.14₹34.35₹28.58
₹50.06₹50.06₹74.78₹32.51₹25.98
—₹42.14₹44.23₹31.97₹90.05
16.916.916.916.916.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GLAXO₹2,498.00

Glaxosmithkline Pharmaceuticals Ltd.

· Pharma & Health
₹ CrorePeersPFIZERABBOTINDIAMEDANTAANTHEMAJANTPHARMIPCALABGLENMARKBIOCONMcap ₹42,319 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS36.0534.8354.5254.5262.01
Diluted EPS36.0534.8354.7654.7663.05
Book Value per Share102.78104.93115.18133.84133.84
Revenue per Share191.94203.87221.31225.59233.45
Cash Flow per Share28.5834.3576.1453.32—
Free Cash Flow per Share25.9832.5174.7850.0650.06
Dividends per Share90.0531.9744.2342.14—
Shares Outstanding (cr)16.916.916.916.916.9
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.